Expand RCUS Menu
RCUS MENU

RCUS Stock Posts


Unusual Option Volume

RCUS Arcus Biosciences23.75-1.39 (-5.5%)

Arcus Biosciences trades 2,974 contracts. The highest volume is in the 17-Apr-26 30 calls, which is 26.3% above the current price. News: Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
View Details...
RCUS #ArcusBiosciences stock declines -8.5% in premarket,

Premarket Decliner

RCUS Arcus Biosciences25.14-0.26-1.0%

Premarket:23.00-2.14 (-8.5%)

Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio

Business WireFri, 12-Dec 8:30 AM
Unusual Option Volume

RCUS Arcus Biosciences22.99+0.94 (+4.3%)

Arcus Biosciences trades 3,278 contracts. The company has the following event: 8th Annual Evercore Healthcare Conference on Dec 2, 2025.
View Details...
RCUS #ArcusBiosciences stock declines -8.9% in premarket,

Premarket Decliner

RCUS Arcus Biosciences20.19-0.10-0.5%

Premarket:18.40-1.79 (-8.9%)

Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock

Business WireThu, 30-Oct 11:35 PM
Unusual Option Volume

RCUS Arcus Biosciences16.31+0.69 (+4.4%)

Arcus Biosciences trades 20,120 contracts.
View Details...
Unusual Option Volume

RCUS Arcus Biosciences14.55+1.20 (+9.0%)

Arcus Biosciences trades 2,673 contracts. The company has the following event: Investor Event to Highlight Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation on Oct 6, 2025. News: Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes